K Pharma
4896.TTSE GROWTHPharmaceutical
Filed as K Pharma, Inc. (2023-11–2026-08)
In English · 6
Mon, Apr 13 · JST1 filing
16:305% STAKEK Pharma · Hideyuki Okano · 11.05% → 10.03%−1.02ppFri, Feb 20 · JST1 filing
16:00MATERIALK Pharma · Change of independent auditorFri, Apr 4 · JST1 filing
16:205% STAKEK Pharma · SBI Ventures Two Co., Ltd. + 2 joint holders · 17.08% → 15.10%−1.98ppThu, Apr 3 · JST1 filing
16:045% STAKEK Pharma · SBI Ventures Two Co., Ltd. + 2 joint holders · 19.14% → 17.08%−2.06ppWed, Apr 2 · JST1 filing
16:265% STAKEK Pharma · SBI Ventures Two Co., Ltd. + 2 joint holders · 20.68% → 19.14%−1.54ppMon, Mar 31 · JST1 filing
16:265% STAKEK Pharma · ITOCHU Technology Ventures, Inc. · 5.13% → 2.02%−3.11ppAll EDINET filings · 45
| Filed | Document | Source |
|---|---|---|
| 2026-08-13 | Half-year report | S100YW0C |
| 2026-03-24 | Annual report | S100XSVP |
| 2025-08-14 | Half-year report | S100WIRK |
| 2025-03-28 | Annual report | S100VIBC |
| 2024-08-14 | Half-year report | S100U7NL |
| 2024-05-14 | Quarterly report | S100TEN7 |
| 2024-03-28 | Annual report | S100T51H |
| 2023-11-13 | Quarterly report | S100S8JN |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected.